• Appalachian Biosciences established in 2015 to develop novel monoclonal antibodies
  • October 2013 – December 2017 - The Nashville site operated as an internal manufacturing site for Berg, LLC
    • Manufactured small molecule clinical supplies
      • Phase I and Phase II in US for parenteral, oral liquid, topical cream, and topical solution
      • April 2017 received QP declaration for Phase II parenteral product for use in EU clinical trial
    • Small and large molecule development
  • PMI Biopharma Solutions, LLC was established in January 2018 by Pathfinder Management, Inc as the major investor